275 related articles for article (PubMed ID: 23671625)
1. Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury.
Yu X; Lu C; Liu H; Rao S; Cai J; Liu S; Kriegel AJ; Greene AS; Liang M; Ding X
PLoS One; 2013; 8(5):e62703. PubMed ID: 23671625
[TBL] [Abstract][Full Text] [Related]
2. LincRNA-p21 promotes mesenchymal stem cell migration capacity and survival through hypoxic preconditioning.
Meng SS; Xu XP; Chang W; Lu ZH; Huang LL; Xu JY; Liu L; Qiu HB; Yang Y; Guo FM
Stem Cell Res Ther; 2018 Oct; 9(1):280. PubMed ID: 30359325
[TBL] [Abstract][Full Text] [Related]
3. Preconditioning of bone marrow-derived mesenchymal stromal cells by tetramethylpyrazine enhances cell migration and improves functional recovery after focal cerebral ischemia in rats.
Li L; Chu L; Fang Y; Yang Y; Qu T; Zhang J; Yin Y; Gu J
Stem Cell Res Ther; 2017 May; 8(1):112. PubMed ID: 28499457
[TBL] [Abstract][Full Text] [Related]
4. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
[TBL] [Abstract][Full Text] [Related]
5. Paracrine effect of CXCR4-overexpressing mesenchymal stem cells on ischemic heart injury.
Wu SZ; Li YL; Huang W; Cai WF; Liang J; Paul C; Jiang L; Wu ZC; Xu M; Zhu P; Wang Y
Cell Biochem Funct; 2017 Mar; 35(2):113-123. PubMed ID: 28233339
[TBL] [Abstract][Full Text] [Related]
6. Suicide gene reveals the myocardial neovascularization role of mesenchymal stem cells overexpressing CXCR4 (MSC(CXCR4)).
Liang J; Huang W; Yu X; Ashraf A; Wary KK; Xu M; Millard RW; Ashraf M; Wang Y
PLoS One; 2012; 7(9):e46158. PubMed ID: 23029422
[TBL] [Abstract][Full Text] [Related]
7. [Effects of hypoxic preconditioning on the migration of bone marrow derived mesenchymal stem cells].
Liu H; Yu XF; Teng J; Zou JZ; Fang Y; Ding XQ
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(10):709-13. PubMed ID: 22781302
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 Antagonist AMD3100 Promotes Mesenchymal Stem Cell Mobilization in Rats Preconditioned with the Hypoxia-Mimicking Agent Cobalt Chloride.
Liu L; Yu Q; Fu S; Wang B; Hu K; Wang L; Hu Y; Xu Y; Yu X; Huang H
Stem Cells Dev; 2018 Apr; 27(7):466-478. PubMed ID: 29433375
[TBL] [Abstract][Full Text] [Related]
9. Differential Regulation of Human Bone Marrow Mesenchymal Stromal Cell Chondrogenesis by Hypoxia Inducible Factor-1α Hydroxylase Inhibitors.
Taheem DK; Foyt DA; Loaiza S; Ferreira SA; Ilic D; Auner HW; Grigoriadis AE; Jell G; Gentleman E
Stem Cells; 2018 Sep; 36(9):1380-1392. PubMed ID: 29726060
[TBL] [Abstract][Full Text] [Related]
10. Bone mesenchymal stem cells pretreated with erythropoietin enhance the effect to ameliorate cyclosporine A-induced nephrotoxicity in rats.
Zhou S; Liu YG; Zhang Y; Hu JM; Liu D; Chen H; Li M; Guo Y; Fan LP; Li LY; Zhao M
J Cell Biochem; 2018 Nov; 119(10):8220-8232. PubMed ID: 29932236
[TBL] [Abstract][Full Text] [Related]
11. The paracrine effect of cobalt chloride on BMSCs during cognitive function rescue in the HIBD rat.
Dai Y; Li W; Zhong M; Chen J; Cheng Q; Liu Y; Li T
Behav Brain Res; 2017 Aug; 332():99-109. PubMed ID: 28576310
[TBL] [Abstract][Full Text] [Related]
12. Hypoxic preconditioning improves the survival and neural effects of transplanted mesenchymal stem cells via CXCL12/CXCR4 signalling in a rat model of cerebral infarction.
Hu Y; Chen W; Wu L; Jiang L; Qin H; Tang N
Cell Biochem Funct; 2019 Oct; 37(7):504-515. PubMed ID: 31368195
[TBL] [Abstract][Full Text] [Related]
13. Evidence for transcriptional regulation of the glucose-6-phosphate transporter by HIF-1alpha: Targeting G6PT with mumbaistatin analogs in hypoxic mesenchymal stromal cells.
Lord-Dufour S; Copland IB; Levros LC; Post M; Das A; Khosla C; Galipeau J; Rassart E; Annabi B
Stem Cells; 2009 Mar; 27(3):489-97. PubMed ID: 19074414
[TBL] [Abstract][Full Text] [Related]
14. VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart.
Tang JM; Wang JN; Zhang L; Zheng F; Yang JY; Kong X; Guo LY; Chen L; Huang YZ; Wan Y; Chen SY
Cardiovasc Res; 2011 Aug; 91(3):402-11. PubMed ID: 21345805
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury.
Si X; Liu X; Li J; Wu X
Int J Clin Exp Pathol; 2015; 8(10):12368-78. PubMed ID: 26722423
[TBL] [Abstract][Full Text] [Related]
16. Migration of CXCR4 gene-modified bone marrow-derived mesenchymal stem cells to the acute injured kidney.
Liu N; Tian J; Cheng J; Zhang J
J Cell Biochem; 2013 Dec; 114(12):2677-89. PubMed ID: 23794207
[TBL] [Abstract][Full Text] [Related]
17. Isoflurane Preconditioning Promotes the Survival and Migration of Bone Marrow Stromal Cells.
Sun Y; Li QF; Yan J; Hu R; Jiang H
Cell Physiol Biochem; 2015; 36(4):1331-45. PubMed ID: 26159215
[TBL] [Abstract][Full Text] [Related]
18. The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury.
Liu H; Liu S; Li Y; Wang X; Xue W; Ge G; Luo X
PLoS One; 2012; 7(4):e34608. PubMed ID: 22511954
[TBL] [Abstract][Full Text] [Related]
19. In vivo magnetic resonance imaging of iron oxide-labeled, arterially-injected mesenchymal stem cells in kidneys of rats with acute ischemic kidney injury: detection and monitoring at 3T.
Ittrich H; Lange C; Tögel F; Zander AR; Dahnke H; Westenfelder C; Adam G; Nolte-Ernsting C
J Magn Reson Imaging; 2007 Jun; 25(6):1179-91. PubMed ID: 17520738
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy.
Tseng WC; Lee PY; Tsai MT; Chang FP; Chen NJ; Chien CT; Hung SC; Tarng DC
Stem Cell Res Ther; 2021 Jun; 12(1):367. PubMed ID: 34183058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
